Table 4 Subgroup analysis of the association with admission WBCc and 30-day mortality
Number of patients | WBCc | P for interaction | |||
|---|---|---|---|---|---|
≤ 11 K/uL | P value | > 11 K/uL | |||
Gender | 0.676 | ||||
Male | 205 | ref | 0.001 | 3.799 (1.695–8.513) | |
Female | 120 | ref | 0.550 | 1.392 (0.471–4.113) | |
Age | 0.013 | ||||
< 69 | 167 | ref | 0.005 | 3.175 (1.412–7.141) | |
≥ 69 | 158 | ref | 0.405 | 1.609 (0.525–4.934) | |
Hypertension | 0.260 | ||||
No | 133 | ref | 0.017 | 3.179 (1.235–8.181) | |
Yes | 192 | ref | 0.067 | 2.286 (0.943–5.543) | |
Diabetes | 0.085 | ||||
No | 298 | ref | 0.013 | 2.378 (1.204–4.694) | |
Yes | 27 | ref | 0.119 | 5.100 (0.658–39.548) | |
HC | 0.529 | ||||
No | 275 | ref | 0.001 | 3.261 (1.636–6.500) | |
Yes | 50 | ref | 0.524 | 0.485 (0.052–4.487) | |
Valvular disease | 0.246 | ||||
No | 292 | ref | 0.003 | 2.843 (1.416–5.709) | |
Yes | 33 | ref | 0.774 | 1.275 (0.242–6.704) | |
CHF | 0.119 | ||||
No | 296 | ref | 0.017 | 2.348 (1.163–4.741) | |
Yes | 29 | ref | 0.999 | / | |
AF | 0.148 | ||||
No | 269 | ref | 0.011 | 2.504 (1.230–5.098) | |
Yes | 56 | ref | 0.153 | 2.960 (0.668–13.118) | |
Liver disease | 1.000 | ||||
No | 315 | ref | 0.002 | 2.738 (1.429–5.248) | |
Yes | 10 | ref | 1.000 | 0.000 | |
Respiratory disease | 0.005 | ||||
No | 262 | ref | 0.024 | 2.369 (1.119–5.015) | |
Yes | 63 | ref | 0.043 | 3.844 (1.046–14.127) | |
AKI | 0.216 | ||||
No | 192 | ref | 0.004 | 3.458 (1.473–8.121) | |
Yes | 133 | ref | 0.256 | 1.761 (0.663–4.679) | |
RRT | 0.129 | ||||
No | 296 | ref | 0.008 | 2.519 (1.269–4.999) | |
Yes | 29 | ref | 0.270 | 2.833 (0.445–18.042) | |